Published in Vaccine Weekly, March 20th, 1995
It has been a quarter of a century since the first attempts to develop vaccines to respiratory syncytial virus ended in failure. Neither formalin inactivated nor live virus vaccines, administered intramuscularly, provided significant protection for infants and both have been associated with enhanced rather than reduced severity of disease on subsequent natural infection.
There are currently a number of candidate vaccines for respiratory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly